STOCK TITAN

CANSORTIUM INC - CNTMF STOCK NEWS

Welcome to our dedicated page for CANSORTIUM news (Ticker: CNTMF), a resource for investors and traders seeking the latest updates and insights on CANSORTIUM stock.

Cansortium Inc (CNTMF) is a leading multi-state operator in the cannabis sector, focusing on cultivation, processing, and dispensing high-quality medical and recreational cannabis products. With a strong presence in key markets like Florida, New York, and Pennsylvania, Cansortium is dedicated to providing patients and consumers with innovative and effective cannabis solutions. The company's robust financial position, strategic partnerships, and commitment to compliance and sustainability set it apart in the industry.

Rhea-AI Summary

Cansortium Inc. (OTCQX: CNTMF) announced the exercise of its first equity cure right under a $71 million credit agreement. The company will utilize proceeds from a recent $2.5 million equity private placement, completed on December 6, 2021, to enhance its EBITDA calculation for the Consolidated Interest Coverage Ratio, which must meet the threshold of 2.00:1.00. This equity cure right can be exercised for up to two consecutive quarters. Cansortium operates under the Fluent™ brand across multiple U.S. states, including Florida and Texas.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.02%
Tags
none
-
Rhea-AI Summary

Cansortium Inc. announced the closing of a non-brokered equity private placement, issuing 3,571,428 common shares at $0.70 per share, raising approximately $2.5 million. The funds will be used for working capital, including potentially exercising an equity cure right under its $71 million Credit Agreement should amendments not be reached with lenders. The securities are not registered under U.S. laws and cannot be offered or sold in the U.S. without proper registration or exemptions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
none
-
Rhea-AI Summary

Cansortium Inc. reported Q3 2021 revenue of $15.6 million, a 9% increase year-over-year, with Florida revenue climbing 4.3% to $13.1 million. Adjusted EBITDA rose 34% to $4.9 million, representing 31.4% of revenue. The company opened new dispensaries, expanding its retail footprint to 29 stores. However, due to market disruptions from a merger among MSOs in Florida, Cansortium revised its 2021 revenue guidance to $63-$66 million, maintaining its adjusted EBITDA forecast of $18-$26 million. Management remains optimistic about production capacity and market positioning moving forward.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.51%
Tags
Rhea-AI Summary

Cansortium Inc. (CSE: TIUM.U, OTCQX: CNTMF) has announced its participation in two upcoming investor conferences in December 2021. The Cowen 4th Annual Cannabis Conference will take place virtually from November 29 to December 1, 2021, with one-on-one meetings on December 1. Additionally, the Benzinga Global Small Cap Conference is scheduled for December 8-9, 2021, where CEO Robert Beasley will present and join a panel discussion. For further details, contact the investor relations team.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.1%
Tags
conferences
-
Rhea-AI Summary

Cansortium Inc. (OTCQX: CNTMF) will hold a conference call on November 30, 2021 at 5:00 p.m. ET to discuss its Q3 2021 financial results for the period ended September 30, 2021. The results will be reported before the call. Interested participants can join using the toll-free dial-in number (800) 319-4610 or the international dial-in (604) 638-5340. The conference will also include a Q&A session and will be available for replay on the Company's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.46%
Tags
none
-
News
Rhea-AI Summary

Cansortium Inc. has announced a change of auditor, replacing MNP LLP with Baker Tilly US, LLP, effective October 1, 2021. The decision follows the Former Auditor's resignation and was approved by the board on October 15, 2021. Notably, there were no modified opinions in the Former Auditor's audit reports for the last two years, and no reportable events occurred between the Company and the Former Auditor. This change is in compliance with National Instrument 51-102 and has been duly filed on SEDAR.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
none
Rhea-AI Summary

Fluent by Cansortium Inc. (OTCQX: CNTMF) announced the opening of its 27th retail location in Florida, located in Fruitland Park. This dispensary, situated near The Villages—one of the fastest-growing metropolitan areas in the U.S.—will offer a variety of cannabis products including Fluent flower and premium oils. CEO Robert Beasley highlighted plans for four additional locations in early 2022, aiming to expand the company's Florida footprint to 31 stores. Fluent emphasizes high-quality cannabis and a welcoming environment for medical marijuana patients in the community.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
none
-
Rhea-AI Summary

Cansortium reported a 24% year-over-year revenue growth in Q2 2021, totaling $16.5 million. The Company achieved adjusted EBITDA of $5.2 million, doubling from the previous year. The significant balance sheet improvement included nearly $90 million for debt cancellation and extended maturities to 2025. Despite minor supply chain delays pushing back production schedules, Cansortium revised its 2021 revenue outlook to $70-$80 million, with adjusted EBITDA expected between $18-$26 million. New dispensaries are opening in Florida and Pennsylvania to support growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.39%
Tags
-
Rhea-AI Summary

Cansortium Inc. has rescheduled its second quarter 2021 conference call to August 25, 2021, at 8:30 a.m. ET. The company will announce its financial results in a press release prior to the call, followed by a Q&A session. Interested parties can join the call using the toll-free number (800) 319-4610 or the international number (604) 638-5340, with the conference ID 10016120. The call will be available for replay on the company's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
none
Rhea-AI Summary

Fluent by Cansortium has announced the approval of a new 43,000 square-foot greenhouse in Homestead, Florida, and a 40,000 square-foot expansion at its Sweetwater facility. These expansions aim to enhance the monthly supply of biomass for producing CBD and THC oil for their dispensaries across Florida. The company recently opened two new dispensaries, bringing its total to 27 by year-end. The new facilities will support the growth of Fluent's CBD and Blend product lines, bolstering its presence in the competitive cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
none

FAQ

What is the current stock price of CANSORTIUM (CNTMF)?

The current stock price of CANSORTIUM (CNTMF) is $0.0841 as of November 22, 2024.

What is the market cap of CANSORTIUM (CNTMF)?

The market cap of CANSORTIUM (CNTMF) is approximately 24.3M.

What is Cansortium Inc's primary focus?

Cansortium Inc is primarily focused on cultivation, processing, and dispensing high-quality medical and recreational cannabis products.

In which key markets does Cansortium operate?

Cansortium has a strong presence in key markets such as Florida, New York, and Pennsylvania.

What sets Cansortium apart in the cannabis industry?

Cansortium is known for its robust financial position, strategic partnerships, and commitment to compliance and sustainability.

How can investors get in touch with Cansortium's CEO?

Investors can contact Robert Beasley, CEO of Cansortium Inc, at (850) 972-8077.

Where can investors find more information about Cansortium Inc?

For more information about Cansortium Inc, visit investors.getFLUENT.com.

What is Cansortium's outstanding debt composition?

Cansortium's outstanding debt consists of a US$66 million senior secured term loan, a US$3.1 million convertible debenture, and US$0.4 million of combined auto, equipment, and insurance financing or loans.

What is the cash position net of debt for Cansortium Inc?

The cash position net of debt is equal to the cash balance of RIV Capital as of March 31, 2024, plus the cash balance of Cansortium as of March 31, 2024, less Cansortium’s outstanding debt of US$69 million as of March 31, 2024.

How does Cansortium calculate adjusted gross profit?

Cansortium calculates adjusted gross profit from gross profit plus (minus) the changes in fair value of biological assets.

What drives Cansortium's success in the cannabis industry?

Cansortium's success is attributed to its innovative products, strategic market presence, and customer-focused approach.

What is the vision of Cansortium Inc for the future?

Cansortium aims to expand its operations, strengthen its market position, and continue providing top-quality cannabis products to consumers.

CANSORTIUM INC

OTC:CNTMF

CNTMF Rankings

CNTMF Stock Data

24.26M
178.07M
34.66%
0.43%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Tampa